Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells Is Associated with a Good Prognosis and Infiltrating Lymphocytes.
Saved in:
| Title: | Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells Is Associated with a Good Prognosis and Infiltrating Lymphocytes. |
|---|---|
| Authors: | Forero A; Department of Medicine, University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama., Li Y; Department of Medicine, University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama., Chen D; Department of Medicine, University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama., Grizzle WE; Department of Pathology, University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama., Updike KL; Department of Oncological Sciences, University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah., Merz ND; Department of Oncological Sciences, University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah., Downs-Kelly E; Department of Pathology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Burwell TC; HudsonAlpha Institute for Biotechnology, Huntsville, Alabama., Vaklavas C; Department of Medicine, University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama., Buchsbaum DJ; Department of Radiation Oncology, University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama., Myers RM; HudsonAlpha Institute for Biotechnology, Huntsville, Alabama. Department of Genetics, University of Alabama at Birmingham, Birmingham, Alabama., LoBuglio AF; Department of Medicine, University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama., Varley KE; Department of Oncological Sciences, University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah. |
| Source: | Cancer immunology research [Cancer Immunol Res] 2016 May; Vol. 4 (5), pp. 390-9. Date of Electronic Publication: 2016 Mar 15. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 26980599 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells Is Associated with a Good Prognosis and Infiltrating Lymphocytes. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Forero+A%22">Forero A</searchLink>; Department of Medicine, University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; Department of Medicine, University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama.<br /><searchLink fieldCode="AU" term="%22Chen+D%22">Chen D</searchLink>; Department of Medicine, University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama.<br /><searchLink fieldCode="AU" term="%22Grizzle+WE%22">Grizzle WE</searchLink>; Department of Pathology, University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama.<br /><searchLink fieldCode="AU" term="%22Updike+KL%22">Updike KL</searchLink>; Department of Oncological Sciences, University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah.<br /><searchLink fieldCode="AU" term="%22Merz+ND%22">Merz ND</searchLink>; Department of Oncological Sciences, University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah.<br /><searchLink fieldCode="AU" term="%22Downs-Kelly+E%22">Downs-Kelly E</searchLink>; Department of Pathology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.<br /><searchLink fieldCode="AU" term="%22Burwell+TC%22">Burwell TC</searchLink>; HudsonAlpha Institute for Biotechnology, Huntsville, Alabama.<br /><searchLink fieldCode="AU" term="%22Vaklavas+C%22">Vaklavas C</searchLink>; Department of Medicine, University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama.<br /><searchLink fieldCode="AU" term="%22Buchsbaum+DJ%22">Buchsbaum DJ</searchLink>; Department of Radiation Oncology, University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama.<br /><searchLink fieldCode="AU" term="%22Myers+RM%22">Myers RM</searchLink>; HudsonAlpha Institute for Biotechnology, Huntsville, Alabama. Department of Genetics, University of Alabama at Birmingham, Birmingham, Alabama.<br /><searchLink fieldCode="AU" term="%22LoBuglio+AF%22">LoBuglio AF</searchLink>; Department of Medicine, University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama.<br /><searchLink fieldCode="AU" term="%22Varley+KE%22">Varley KE</searchLink>; Department of Oncological Sciences, University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101614637%22">Cancer immunology research</searchLink> [Cancer Immunol Res] 2016 May; Vol. 4 (5), pp. 390-9. <i>Date of Electronic Publication: </i>2016 Mar 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101614637 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2326-6074 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223266066%22">23266066 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26980599 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/2326-6066.CIR-15-0243 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 390 Titles: – TitleFull: Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells Is Associated with a Good Prognosis and Infiltrating Lymphocytes. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Forero A – PersonEntity: Name: NameFull: Li Y – PersonEntity: Name: NameFull: Chen D – PersonEntity: Name: NameFull: Grizzle WE – PersonEntity: Name: NameFull: Updike KL – PersonEntity: Name: NameFull: Merz ND – PersonEntity: Name: NameFull: Downs-Kelly E – PersonEntity: Name: NameFull: Burwell TC – PersonEntity: Name: NameFull: Vaklavas C – PersonEntity: Name: NameFull: Buchsbaum DJ – PersonEntity: Name: NameFull: Myers RM – PersonEntity: Name: NameFull: LoBuglio AF – PersonEntity: Name: NameFull: Varley KE IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2016 May Type: published Y: 2016 Identifiers: – Type: issn-electronic Value: 2326-6074 Numbering: – Type: volume Value: 4 – Type: issue Value: 5 Titles: – TitleFull: Cancer immunology research Type: main |
| ResultId | 1 |